Tracey McCain
Compliance Officer chez BLUEPRINT MEDICINES CORPORATION
Fortune : 6 M $ au 30/04/2024
Postes actifs de Tracey McCain
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Compliance Officer | 06/09/2016 | - |
| Conseiller Juridique Général | 06/09/2016 | - | |
| Secrétaire Général | 06/09/2016 | - | |
| KINIKSA PHARMACEUTICALS, LTD. | Directeur/Membre du Conseil | 01/02/2018 | - |
| Independent Dir/Board Member | 01/02/2018 | - |
Historique de carrière de Tracey McCain
Anciens postes connus de Tracey McCain
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| IMMUNOGEN, INC. | Directeur/Membre du Conseil | 15/11/2021 | 12/02/2024 |
| Independent Dir/Board Member | 15/11/2021 | 12/02/2024 | |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Conseiller Juridique Général | 01/01/2016 | 02/09/2016 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Conseiller Juridique Général | 01/05/1997 | 01/09/2016 |
| Palmer & Dodge LLP | Corporate Officer/Principal | - | - |
Formation de Tracey McCain
| University of Pennsylvania | Undergraduate Degree |
| Columbia Law School | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 8 |
| Royaume-Uni | 2 |
Opérationnelle
| General Counsel | 3 |
| Director/Board Member | 2 |
| Independent Dir/Board Member | 2 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BLUEPRINT MEDICINES CORPORATION | Health Technology |
| KINIKSA PHARMACEUTICALS, LTD. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
| Palmer & Dodge LLP | Commercial Services |
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Tracey McCain
- Expérience
